Douglas W. Pagan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas W. Pagan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas W. Pagan. Douglas W. Pagan is Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Chief Financial Officer in Paratek Pharmaceuticals, Inc. ($PRTK) and Chief Financial Officer in Dicerna Pharmaceuticals Inc ($DRNA).
Latest Insider Trading Transactions of Douglas W. Pagan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DRNA, PRTK, ZIOP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | DRNA | Dicerna Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 24.05 | 36,900 | 887,445 | 36,900 | |
| Jan 12 2021 | DRNA | Dicerna Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,200 | 0 | 8,200 | |
| Jun 02 2020 | DRNA | Dicerna Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 20.79 | 95,650 | 1,988,564 | 95,650 | |
| Jun 02 2020 | DRNA | Dicerna Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 0.00 | 27,300 | 0 | 27,300 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Option Exercise | A | 4.72 | 25,281 | 119,326 | 25,281 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Payment of Exercise | F | 4.72 | 20,054 | 94,655 | 35,943 | 56 K to 35.9 K (-35.81 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Grant | A | 0.00 | 15,890 | 0 | 55,997 | 40.1 K to 56 K (+39.62 %) |
| Apr 08 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 30,000 | 0 | 100,807 | 70.8 K to 100.8 K (+42.37 %) |
| Apr 08 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | D | 0.00 | 16,250 | 0 | 70,807 | 87.1 K to 70.8 K (-18.67 %) |
| Apr 08 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | D | 0.00 | 27,500 | 0 | 87,057 | 114.6 K to 87.1 K (-24.01 %) |
| Apr 08 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | D | 0.00 | 37,000 | 0 | 114,557 | 151.6 K to 114.6 K (-24.41 %) |
| Apr 08 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | D | 0.00 | 19,500 | 0 | 151,557 | 171.1 K to 151.6 K (-11.40 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 37,000 | 0 | 171,057 | 134.1 K to 171.1 K (+27.60 %) |
| Feb 07 2019 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 6.77 | 2,495 | 16,891 | 134,057 | 136.6 K to 134.1 K (-1.83 %) |
| Jan 02 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Option Exercise | A | 1.87 | 63,350 | 118,465 | 63,350 | |
| Jan 02 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Grant | A | 0.00 | 40,107 | 0 | 40,107 | 0 to 40.1 K |
| Dec 14 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 6.76 | 2,918 | 19,726 | 120,302 | 123.2 K to 120.3 K (-2.37 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 8.96 | 2,784 | 24,945 | 123,220 | 126 K to 123.2 K (-2.21 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 8.96 | 2,784 | 24,945 | 123,220 | 126 K to 123.2 K (-2.21 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 6,500 | 0 | 126,004 | 119.5 K to 126 K (+5.44 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 6,500 | 0 | 126,004 | 119.5 K to 126 K (+5.44 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 9.82 | 7,579 | 74,426 | 119,504 | 127.1 K to 119.5 K (-5.96 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 27,500 | 0 | 127,083 | 99.6 K to 127.1 K (+27.62 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 22,500 | 0 | 99,583 | 77.1 K to 99.6 K (+29.19 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 12.70 | 5,237 | 66,510 | 77,083 | 82.3 K to 77.1 K (-6.36 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 12.70 | 5,237 | 66,510 | 77,083 | 82.3 K to 77.1 K (-6.36 %) |
| Apr 05 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 13,500 | 0 | 82,320 | 68.8 K to 82.3 K (+19.62 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 29,250 | 0 | 68,820 | 39.6 K to 68.8 K (+73.92 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 14.22 | 16,291 | 231,658 | 39,570 | 55.9 K to 39.6 K (-29.16 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 23.58 | 4,139 | 97,593 | 55,861 | 60 K to 55.9 K (-6.90 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 60,000 | 51 K to 60 K (+17.65 %) |
| Jun 21 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 25.00 | 4,595 | 114,875 | 51,000 | 55.6 K to 51 K (-8.27 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.09 | 25 | 377 | 55,595 | 55.6 K to 55.6 K (-0.04 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.05 | 1,186 | 17,849 | 55,620 | 56.8 K to 55.6 K (-2.09 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.08 | 17 | 256 | 56,806 | 56.8 K to 56.8 K (-0.03 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.10 | 1,428 | 21,563 | 56,823 | 58.3 K to 56.8 K (-2.45 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.15 | 732 | 11,090 | 58,251 | 59 K to 58.3 K (-1.24 %) |
| Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Sell | S | 15.20 | 17 | 258 | 58,983 | 59 K to 59 K (-0.03 %) |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 15.10 | 45,000 | 679,500 | 45,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 14.05 | 48,000 | 674,400 | 48,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Grant | A | 0.00 | 24,000 | 0 | 59,000 | 35 K to 59 K (+68.57 %) |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 24.07 | 160,000 | 3,851,200 | 160,000 | |
| Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Pagan Douglas W. | Chief Financial Off ... | Option Exercise | A | 24.07 | 35,000 | 842,450 | 35,000 |
Page: 1